全文获取类型
收费全文 | 38789篇 |
免费 | 2491篇 |
国内免费 | 97篇 |
专业分类
耳鼻咽喉 | 448篇 |
儿科学 | 1434篇 |
妇产科学 | 945篇 |
基础医学 | 4731篇 |
口腔科学 | 462篇 |
临床医学 | 6453篇 |
内科学 | 6718篇 |
皮肤病学 | 401篇 |
神经病学 | 3723篇 |
特种医学 | 799篇 |
外国民族医学 | 1篇 |
外科学 | 3574篇 |
综合类 | 362篇 |
一般理论 | 49篇 |
预防医学 | 5501篇 |
眼科学 | 403篇 |
药学 | 2362篇 |
中国医学 | 44篇 |
肿瘤学 | 2967篇 |
出版年
2024年 | 30篇 |
2023年 | 323篇 |
2022年 | 449篇 |
2021年 | 847篇 |
2020年 | 602篇 |
2019年 | 938篇 |
2018年 | 1092篇 |
2017年 | 812篇 |
2016年 | 851篇 |
2015年 | 945篇 |
2014年 | 1328篇 |
2013年 | 2093篇 |
2012年 | 3033篇 |
2011年 | 3213篇 |
2010年 | 1711篇 |
2009年 | 1550篇 |
2008年 | 2784篇 |
2007年 | 2792篇 |
2006年 | 2732篇 |
2005年 | 2685篇 |
2004年 | 2473篇 |
2003年 | 2196篇 |
2002年 | 2107篇 |
2001年 | 234篇 |
2000年 | 199篇 |
1999年 | 266篇 |
1998年 | 434篇 |
1997年 | 337篇 |
1996年 | 260篇 |
1995年 | 209篇 |
1994年 | 216篇 |
1993年 | 208篇 |
1992年 | 129篇 |
1991年 | 115篇 |
1990年 | 92篇 |
1989年 | 99篇 |
1988年 | 90篇 |
1987年 | 79篇 |
1986年 | 83篇 |
1985年 | 82篇 |
1984年 | 99篇 |
1983年 | 76篇 |
1982年 | 90篇 |
1981年 | 99篇 |
1980年 | 70篇 |
1979年 | 41篇 |
1978年 | 31篇 |
1977年 | 38篇 |
1976年 | 21篇 |
1975年 | 24篇 |
排序方式: 共有10000条查询结果,搜索用时 11 毫秒
991.
Eldad Elnekave MD Joseph P. Erinjeri MD Karen T. Brown MD Raymond H. Thornton MD Elena N. Petre MD Majid Maybody MD Mary A. Maluccio MD Meier Hsu MS Constantinos T. Sofocleous MD George I. Getrajdman MD Lynn A. Brody MD Stephen B. Solomon MD William Alago MD Yuman Fong MD William R. Jarnagin MD Anne M. Covey MD 《Annals of surgical oncology》2013,20(9):2881-2886
Background
Resection has been the standard of care for patients with solitary hepatocellular carcinoma (HCC). Transarterial embolization and percutaneous ablation are alternative therapies often reserved for suboptimal surgical candidates. Here we compare long-term outcomes of patients with solitary HCC treated with resection versus combined embo-ablation.Methods
We previously reported a retrospective comparison of resection and embo-ablation in 73 patients with solitary HCC <7 cm after a median follow-up of 23 months. This study represents long-term updated follow-up over a median of 134 months.Results
There was no difference in survival among Okuda I patients who underwent resection versus embo-ablation (66 vs 58 months, p = .39). There was no difference between the groups in the rate of distant intrahepatic (p = .35) or metastatic progression (p = .48). Surgical patients experienced more complications (p = .004), longer hospitalizations (p < .001), and were more likely to require hospital readmission within 30 days of discharge (p = .03).Conclusion
Over a median follow up of more than 10 years, we found no significant difference in overall survival of Okuda 1 patients with solitary HCC <7 cm who underwent surgical resection versus embo-ablation. Our data suggest that there may be a greater role for primary embo-ablation in the treatment of potentially resectable solitary HCC. 相似文献992.
Margaret L. Crivello MD Karen Ruth MS Elin R. Sigurdson MD PhD Brian L. Egleston PhD Kathryn Evers MD Yu-Ning Wong MD Marcia Boraas MD Richard J. Bleicher MD 《Annals of surgical oncology》2013,20(1):102-110
Background
Guidelines for breast cancer staging exist, but adherence remains unknown. This study evaluates patterns of imaging in early stage breast cancer usually reserved for advanced disease.Methods
Surveillance Epidemiology, and End Results data linked to Medicare claims from 1992–2005 were reviewed for stage I/II breast cancer patients. Claims were searched for preoperative performance of computed tomography (CT), positron emission tomography (PET), bone scans, and brain magnetic resonance imaging (MRI) (“advanced imaging”).Results
There were 67,874 stage I/II breast cancer patients; 18.8 % (n = 12,740) had preoperative advanced imaging. The proportion of patients having CT scans, PET scans, and brain MRI increased from 5.7 % to 12.4 % (P < 0.0001), 0.8 % to 3.4 % (P < 0.0001) and 0.2 % to 1.1 % (P = 0.008), respectively, from 1992 to 2005. Bone scans declined from 20.1 % to 10.7 % (P < 0.0001). “Breast cancer” (174.x) was the only diagnosis code associated with 62.1 % of PET scans, 37.7 % of bone scans, 24.2 % of CT, and 5.1 % of brain MRI. One or more symptoms or metastatic site was suggested for 19.6 % of bone scans, 13.0 % of CT, 13.0 % of PET, and 6.2 % of brain MRI. Factors associated (P < 0.05) with use of all modalities were urban setting, breast MRI and ultrasound. Breast MRI was the strongest predictor (P < 0.0001) of bone scan (odds ratio [OR] 1.63, 95 % confidence interval [CI] 1.44–1.86), Brain MRI (OR 1.74, 95 % CI 1.15–2.63), CT (OR 2.42, 95 % CI 2.12–2.76), and PET (OR 5.71, 95 % CI 4.52–7.22).Conclusions
Aside from bone scans, performance of advanced imaging is increasing in early stage Medicare breast cancer patients, with limited rationale provided by coded diagnoses. In light of existing guidelines and increasing scrutiny about health care costs, greater reinforcement of current indications is warranted. 相似文献993.
994.
Karen D. Ethans Patricia W. Nance Robert J. Bard Alan R. Casey Orpha I. Schryvers 《The journal of spinal cord medicine》2013,36(3):214-218
AbstractObjective: To compare tolterodine with oxybutynin and placebo in people with neuragenie detrusor overactivity.Design: Prospective, randomized, double-blind, crossover trial plus open-label comparative stage.Participants: Ten participants with neuragenie detrusor overactivity due to spinal cord injury or multiple sclerosis who usedintermittent catheterization.Methods: Bladder capacity on cystometrogram, a 10-day record of catheterization volumes, number of incontinent episodes perday, and perceived dry mouth using a visual analog scale (VAS) were measured for the following: (a) a blinded comparison:tolterodine, 2 mg twice daily, vs placebo, twice daily; and (b) an unblinded comparison: oxybutynin vs tolterodine, each atself-selected doses (SSDs).Results: Tolterodine, 2 mg twice daily, was superior to placebo in enhancing catheterization volumes (P<0.0005) and reducingincontinence (P<0.001 ), but was comparable with placebo in cystometric bladder capacity. Efficacy of tolterodine SSD wascomparable with oxybutynin SSD with regard to catheterization volumes, degree of incontinence, and cystometric bladder capacity.The side effect profile (dry mouth) was comparable between tolterodine, 2 mg twice daily, and placebo, but differed significantlywhen comparing tolterodine SSD with oxybutynin SSD (P<0.05).Conclusion: T olterodine, when used at SSDs, is comparable with oxybutynin at SSDs in enhancing bladder volume and improvingcontinence, but with less dry mouth. T olterodine at the recommended dosage of 2 mg twice daily improves incontinence and bladdervolumes compared with placebo, and without significant dry mouth. Larger doses of tolterodine may be needed to achieve best effectin this population, but further studies are required. 相似文献
995.
Florian Lordick Arnulf H. Hölscher Karen Haustermans Christian Wittekind 《Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie》2013,398(2):177-187
Background
The treatment of localized esophageal cancer has been debated controversially over the past decades. Neoadjuvant treatment was used empirically, but evidence was limited due to the lack of high-quality confirmatory studies. Meanwhile, data have become much clearer due to recently published well-conducted randomized controlled trials and meta-analyses.Methods
Neoadjuvant and perioperative platinum fluoropyrimidine-based combination chemotherapy has now an established role in the treatment of stage II and stage III esophageal adenocarcinoma and cancer of the esophago-gastric junction. Neoadjuvant chemoradiation is now the standard of care for treating stage II and stage III esophageal squamous cell cancer and can also be considered for treating esophageal adenocarcinoma.Results
Patients with esophageal squamous cell cancer treated with definitive chemoradiation achieve comparable long-term survival compared with surgery. Short-term mortality is less with chemoradiation alone, but local tumor control is significantly better with surgery.Conclusion
This expert review article outlines current data and literature and delineates recommendable treatment guidelines for localized esophageal cancer. 相似文献996.
Dana A. Ohl Johan Denil Karen Fitzgerald-Shelton Marcianna McCabe Edward J. McGuire Alan C. Menge 《The journal of spinal cord medicine》2013,36(2):53-59
ABSTRACTThirty-eight men undergoing electroejaculation (EEJ) procedures for anejaculatory infertility were examined for the presence or absence of infection in urine and semen. In 29 spinal cord injury patients, a high incidence of infected urine and infected semen (41% and 56%, respectively) was seen, in contrast to patients with normal bladder function (0% and 11 %).Urinary infection was associated with slightly lower sperm quality and lower pregnancy rates (10% vs 30% in the presence of sterile urine). Semen infection had no effect on sperm counts or pregnancy rates. If intermittent self-catheterization (ISC) was used to empty the neurogenic bladder, slightly better sperm quality was seen, the total failure rate was less, and much better pregnancy rates (44%) resulted than for patients using an alternative bladder management (7%).Antibiotics did not reduce the incidence of urine or semen infection, but did improve sperm counts slightly. Continuous prophylaxis was associated with bacterial resistance to many oral antibiotics and had no advantage over a short course of antibiotics prior to the procedure.Despite the above associations, the sperm quality in our patient population was never normal compared with that of men who ejaculate normally. We conclude that the low sperm quality seen in electroejaculation specimens from spinal cord injured males is not due entirely to infection or to the type of bladder management. Short courses of antibiotics, instead of continuous antibiotic prophylaxis, may be beneficial. Intermittent catheterization is superior to other methods of neurogenic bladder management in maintaining the fertility of spinal cord injured men. 相似文献
997.
998.
Damian Balmforth Andrea Bille Lawrence Okiror Karen Harrsion-Phipps Tom Routledge 《General thoracic and cardiovascular surgery》2013,61(4):231-233
Pleural effusions as part of the yellow nail syndrome (YNS) can often be recurrent, requiring multiple thoracocentesis. The optimal surgical treatment of such recurrent effusions remains unclear and various methods including thoracoscopic pleurodesis, pleuroperitioneal shunts and pleurectomy have been described. We report two cases of recurrent pleural effusions in YNS, the first case with bilateral effusions and the second with right-sided effusions treated 2 months apart from bilateral long-term tunnelled catheters and thoracoscopic pleurectomy and compare the results of the two treatment strategies. 相似文献
999.
Michael A. Muniak Alejandro Rivas Karen L. Montey Bradford J. May Howard W. Francis David K. Ryugo 《The Journal of comparative neurology》2013,521(7):1510-1532
The relationship between structure and function is an invaluable context with which to explore biological mechanisms of normal and dysfunctional hearing. The systematic and topographic representation of frequency originates at the cochlea, and is retained throughout much of the central auditory system. The cochlear nucleus (CN), which initiates all ascending auditory pathways, represents an essential link for understanding frequency organization. A model of the CN that maps frequency representation in 3D would facilitate investigations of possible frequency specializations and pathologic changes that disturb frequency organization. Toward this goal, we reconstructed in 3D the trajectories of labeled auditory nerve (AN) fibers following multiunit recordings and dye injections in the anteroventral CN of the CBA/J mouse. We observed that each injection produced a continuous sheet of labeled AN fibers. Individual cases were normalized to a template using 3D alignment procedures that revealed a systematic and tonotopic arrangement of AN fibers in each subdivision with a clear indication of isofrequency laminae. The combined dataset was used to mathematically derive a 3D quantitative map of frequency organization throughout the entire volume of the CN. This model, available online ( http://3D.ryugolab.com/ ), can serve as a tool for quantitatively testing hypotheses concerning frequency and location in the CN. J. Comp. Neurol. 521:1510–1532, 2013. © 2012 Wiley Periodicals, Inc. 相似文献
1000.
Leif Johannsen Karen Z.H. Li Magdalena Chechlacz Attia Bibi Zoe Kourtzi Alan M. Wing 《Neuropsychologia》2013